-
Editor's Letter
Cancer and Watchful WaitingWatching and waiting for cancer to progress can be an alternative to active treatment.
by Kevin McLaughlin
-
Forward Look
Getting to the Root of Brain CancerQ&A with neurosurgeon Peter Dirks on stem cells and brain cancer.
by Chris Palmer
-
Forward Look
Cancer Centers Unite to Increase HPV Vaccination RatesJoint statement recommends girls and boys be vaccinated before age 13.
by Cameron Walker
-
Forward Look
Breast Cancer Survivors and Vaginal EstrogenExpert opinion affirms need to weigh risks and benefits.
by Kate Yandell
-
Forward Look
A Report Card on Active SurveillanceMany men with untreated prostate cancer are not getting proper follow-up.
by Heather Stringer
-
Forward Look
Radiation Appointments Are Numerous, And NecessaryNew study shows impact of missed treatments.
by Marilyn Fenichel
-
Treatment Is Waiting
For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
-
The Riddle of Bacteria and Cancer
Bacteria can be friend or foe—or both. Researchers are looking at bacteria to boost the effectiveness of cancer treatments, even if they don't fully understand how the tiny organisms work.
by Stephen Ornes
-
Forward Look
Aspirin Recommended to Reduce Colorectal Cancer RiskTask force formally recognizes the benefits, with caveats.
by Yasmine Iqbal
-
Forward Look
Fine-Tuning Treatments for Triple-Negative Breast CancerStudies aim to identify best available treatments and find new ones.
by Cameron Walker
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore